Molecular mechanism of angiogenesis Transcription factors and their therapeutic relevance
- 27 July 2000
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 87 (1) , 51-60
- https://doi.org/10.1016/s0163-7258(00)00067-x
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31Oncogene, 2000
- Roles of Extracellular Signal‐regulated Kinase 1/2 and p38 Mitogen‐activated Protein Kinase in the Signal Transduction of Basic Fibroblast Growth Factor in Endothelial Cells during AngiogenesisJapanese Journal of Cancer Research, 1999
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- Induction of Ets-1 in endothelial cells during reendothelialization after denuding injuryJournal of Cellular Physiology, 1998
- The SCL gene specifies haemangioblast development from early mesodermThe EMBO Journal, 1998
- Mechanisms of angiogenesisNature, 1997
- The TEL gene products: nuclear phosphoproteins with DNA binding propertiesOncogene, 1997
- Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α SubunitJournal of Biological Chemistry, 1996
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCLNature, 1995